We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.49B
AUM Growth
+$113M
Cap. Flow
+$75.7M
Cap. Flow %
1.69%
Top 10 Hldgs %
35.01%
Holding
643
New
28
Increased
86
Reduced
146
Closed
38

Top Buys

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$21.7M
2
META icon
Meta Platforms (Facebook)
META
+$17.5M
3
AMT icon
American Tower
AMT
+$10.6M
4
DHR icon
Danaher
DHR
+$8.77M
5
SBUX icon
Starbucks
SBUX
+$8.06M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$10.4M
2
PX
Praxair Inc
PX
+$8.76M
3
IDXX icon
Idexx Laboratories
IDXX
+$4.94M
4
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$3.42M
5
FISV
Fiserv Inc
FISV
+$2.36M

Sector Composition

Rank Sector Weight
1 Technology 23.07%
2 Healthcare 17.68%
3 Consumer Staples 12.48%
4 Consumer Discretionary 10%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVC
501
Service Properties Trust
SVC
$1.1B
$14K ﹤0.01%
+86
New +$12.5K
VAR
502
DELISTED
Varian Medical Systems, Inc.
VAR
$14K ﹤0.01%
182
– –
ATHN
503
DELISTED
Athenahealth, Inc.
ATHN
$14K ﹤0.01%
133
– –
RBS.PRL.CL
504
DELISTED
Royal Bank Of Scotland Group Plc
RBS.PRL.CL
$14K ﹤0.01%
+600
New +$14.8K
AVAV icon
505
AeroVironment
AVAV
$9.81B
$13K ﹤0.01%
500
– –
EVF
506
Eaton Vance Senior Income Trust
EVF
$91.4M
$13K ﹤0.01%
+1,876
New +$12.1K
ODP
507
DELISTED
ODP
ODP
$13K ﹤0.01%
298
– –
PSMT icon
508
Pricesmart
PSMT
$5.49B
$13K ﹤0.01%
160
– –
UONEK icon
509
Urban One Class D
UONEK
$23.5M
$13K ﹤0.01%
450
– –
WAFD icon
510
WaFd
WAFD
$2.79B
$13K ﹤0.01%
375
-125
-25% -$3.82K
WELL icon
511
Welltower
WELL
$166B
$13K ﹤0.01%
200
– –
WTS icon
512
Watts Water Technologies
WTS
$12.9B
$13K ﹤0.01%
200
– –
AVNS
513
DELISTED
Avanos Medical
AVNS
$12K ﹤0.01%
326
+137
+72% +$4.9K
C icon
514
Citigroup
C
$231B
$12K ﹤0.01%
200
+163
+441% +$8.79K
CRSP icon
515
CRISPR Therapeutics
CRSP
$5.22B
$12K ﹤0.01%
+600
New +$11.2K
HUBB icon
516
Hubbell
HUBB
$27.1B
$12K ﹤0.01%
100
– –
WPG
517
DELISTED
Washington Prime Group Inc.
WPG
$12K ﹤0.01%
128
– –
AMX icon
518
America Movil
AMX
$69.7B
$11K ﹤0.01%
843
– –
AU icon
519
AngloGold Ashanti
AU
$49.5B
$11K ﹤0.01%
1,000
– –
BATRK icon
520
Atlanta Braves Holdings Series B
BATRK
$3.4B
$11K ﹤0.01%
537
-31
-5% -$578
CVE icon
521
Cenovus Energy
CVE
$55.6B
$11K ﹤0.01%
725
– –
B
522
Barrick Mining
B
$67.9B
$11K ﹤0.01%
700
– –
IJK icon
523
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$11K ﹤0.01%
252
-360
-59% -$15.8K
KYN icon
524
Kayne Anderson Energy Infrastructure Fund
KYN
$2.5B
$11K ﹤0.01%
+557
New +$10.8K
LILAK icon
525
Liberty Latin America Class C
LILAK
$1.67B
$11K ﹤0.01%
630
– –
19 20
21
22 23

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Loring Wolcott & Coolidge Fiduciary Advisors held 643 positions worth $4.49B, up 2.6% from $4.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2016 filing shows 28 new, 86 increased, 146 reduced and 38 closed positions. Its largest new stake was Adient: 27,453 shares worth $1.61M. The largest sale was Novo Nordisk, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2016 buy was Adient: 27,453 shares worth $1.61M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Paycom in Q4 2016, an estimated $21.7M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2016 reduction was Novo Nordisk, cutting an estimated $10.4M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Invesco Water Resources ETF in Q4 2016, selling an estimated $148K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 35% of its $4.49B portfolio in Q4 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 28 new positions and closed 38 in Q4 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 2.6% quarter-over-quarter to $4.49B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2016, filed 2 Feb 2017.